Nivolumab plus chemotherapy in first-line metastatic non-small-cell lung cancer: results of the phase III CheckMate 227 Part 2 trial
- Borghaei, H.
- O'Byrne, K.J.
- Paz-Ares, L.
- Ciuleanu, T.-E.
- Yu, X.
- Pluzanski, A.
- Nagrial, A.
- Havel, L.
- Kowalyszyn, R.D.
- Valette, C.A.
- Brahmer, J.R.
- Reck, M.
- Ramalingam, S.S.
- Zhang, L.
- Ntambwe, I.
- Rabindran, S.K.
- Nathan, F.E.
- Balli, D.
- Wu, Y.-L.
Journal:
ESMO Open
ISSN: 2059-7029
Year of publication: 2023
Volume: 8
Issue: 6
Type: Article